With any software, the more you use it, the more hacks and shortcuts you discover, and never a truer word has been said when ...

One of the most critical parts of any mouse is the scroll wheel due to how helpful it is for scrolling through lengthy pages. Users will find it frustrating if their mouse scroll wheel doesn’t work in ...

Type: Bug After updating to the latest VS Code version, code content bleeds into the scroll bar area. Currently, scroll bar annotation markers as well as the scroll bars themselves are interleaved ...

PORTLAND, Ore. (KOIN) — Another LGBTQ-friendly Portland watering hole is bidding farewell, this time to the lesbian community. Doc Marie’s announced on Wednesday that it will soon close its doors. The ...

Every morning, across homes in Pakistan, there’s one common sight. A kid running out the door in a freshly ironed white ...

You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. Follow Lakshmi Varanasi Every time Lakshmi publishes a story, you’ll get an alert straight to your ...

More Britons get their winter sports fix in Val d’Isère every year than anywhere else in the world – and with good reason.

Fintech company AlphaSense has acquired Carousel, an AI assistant for building financial models in Excel. AlphaSense CEO Jack Kokko told BI that "AI isn't replacing analysts, it's giving them ...

Meta’s AI-powered ads will drive its long-term growth. ASML will remain the linchpin of the global semiconductor market. CrowdStrike’s cloud-native cybersecurity services will replace on-site ...

A salabhanjika, dubbed the Mona Lisa of India by the tourism industry, at Gwalior’s Gujari Mahal Archaeological Museum. | Kamayani Sharma. It’s not very often that one sees a deity behind bars. It is ...

Enbridge has increased its dividend annually for the past 30 years. The energy company should have plenty of fuel to continue increasing its dividend, currently yielding 5.8%. That's why I recently ...

The FDA today unveiled a plan to accelerate development of biosimilars in hopes of significantly reducing drug costs in the United States.